4th DRUG DISCOVERY FOR NEURODEGENERATION

CONFERENCE

Presented by the Alzheimer's Drug Discovery Foundation

February 1-2, 2010  ●  Houston, TX - USA

HOME   ●   PROGRAM   ●   SPEAKERS   ●   SCHOLARSHIPS   ●   REGISTRATION   ●   CME   ●   ACCOMMODATIONS   ●   SPONSORSHIP   ●   SUPPORTERS   ●   CONTACT

ABOUT THE MEETING
The purpose of the conference is to advance drug discovery for neurodegenerative diseases by educating scientists on the process of translating basic research into novel therapies. 

Speakers and chairs presented lectures and case studies on Alzheimerís disease, Parkinsonís disease, Huntingtonís disease, ALS, MS, and other orphan neurological diseases.

SESSIONS

Session I. Basics of Medicinal Chemistry

Session II. In-vitro Testing: Early Phases of Drug Discovery

Session III. Pre-Clinical Proof-of-Concept and Development

Session IV. Issues in Technology Transfer: Interactions and Intellectual Property

Session V. Case Studies

Session VI. Resources and Services for Advancing Drug Discovery

Review program details here.

COURSE OBJECTIVES
  • Discuss the principles of drug discovery for neurodegenerative disease.

  • Exchange ideas, knowledge and resources about drug discovery for neurodegenerative disease.

  • Stimulate pre-clinical research in the discovery and testing of novel compounds aimed at the prevention and treatment of neurodegenerative disease.

  • Build public-private partnerships that will accelerate drug discovery for neurodegenerative disease.

2010 and 2009 WEBCASTS

The 2009 Drug Discovery for Neurodegeneration Conference presentations are available on demand. 

Click here to view the 2010 videocasts.

Click here to view the 2009 slidecasts.

 

CME

The conference offered continuing medical education credits.  Review information at the CME page.

TARGET AUDIENCE

  • Academic and industry scientists engaged in drug discovery research for neurodegenerative diseases or CNS

  • Business development and licensing professionals

  • Alliance management professionals

  • Venture capitalists and other investors.

SCHOLARSHIPS and AWARDS

The Alzheimerís Drug Discovery Foundation invited applications for the 2010 ADDF Outstanding Young Investigator Awards and the ADDF Young Investigator Scholarships. 

Review the 2010 awardees and scholars.

SPONSORSHIP and EXHIBIT

The conference offered great opportunities to expand your company's visibility among the registrants by becoming a conference sponsor and/or exhibitor. 

Review details and benefits here.

  Share
The Drug Discovery for Neurodegeneration Conference is presented by the Alzheimer's Drug Discovery Foundation (ADDF), the only public charity solely dedicated to rapidly accelerating the discovery and development of drugs to prevent, treat and cure Alzheimer's disease, related dementias and cognitive aging. 

 

www.alzdiscovery.org © 2009 ADDF